
Results of the NGR-hTNF Mesothelioma Clinical Trial Now Available
Today, MolMed, an Italian pharmaceutical company, released results from its NGR-hTNF for mesothelioma clinical trial. While the trial, which enrolled 400 pleural mesothelioma patients, demonstrated






